In this multicenter randomized study treatment with CytoSorb, a novel extracorporeal cytokine adsorber, lead to a substantial removal of Il-6 in a severely ill patient population with primarily septic shock, ARDS, and multi-organ failure. This evidence concerns the gene IL6 and acute respiratory distress syndrome.